Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines

1999371 citationsJournal Article

Authors

Jordan W. Tappero · Centers for Disease Control and Prevention

Rosalba Lagos

A. Maldonado Ballesteros

Abstract

These data suggest that neither serogroup B OMP meningococcal vaccine would confer protection during a heterologous epidemic. However, epidemic strain-specific vaccines homologous for class 1 OMP are promising candidates for the control of epidemic serogroup B meningococcal disease.

Topics & Keywords

Bacterial Infections and Vaccines Pneumonia and Respiratory Infections Neonatal and Maternal Infections

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 281, Issue 16, pp. 1520-7

DOI: 10.1001/jama.281.16.1520

Field-Weighted Citation Impact: 10.18